Literature DB >> 23478967

Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms.

Wen-Chi Chiang1, Martin Nilsson, Peter Østrup Jensen, Niels Høiby, Thomas E Nielsen, Michael Givskov, Tim Tolker-Nielsen.   

Abstract

Within recent years, it has been established that extracellular DNA is a key constituent of the matrix of microbial biofilms. In addition, it has recently been demonstrated that DNA binds positively charged antimicrobials such as aminoglycosides and antimicrobial peptides. In the present study, we provide evidence that extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms. We show that exogenously supplemented DNA integrates into P. aeruginosa biofilms and increases their tolerance toward aminoglycosides. We provide evidence that biofilms formed by a DNA release-deficient P. aeruginosa quorum-sensing mutant are more susceptible to aminoglycoside treatment than wild-type biofilms but become rescued from the detrimental action of aminoglycosides upon supplementation with exogenous DNA. Furthermore, we demonstrate that exposure to lysed polymorphonuclear leukocytes, which are thought to be a source of extracellular DNA at sites of infections, increases the tolerance of P. aeruginosa biofilms toward aminoglycosides. Although biofilm-associated aminoglycoside tolerance recently has been linked to extracellular DNA-mediated activation of the pmr genes, we demonstrate that the aminoglycoside tolerance mediated by the presence of extracellular DNA is not caused by activation of the pmr genes in our P. aeruginosa biofilms but rather by a protective shield effect of the extracellular DNA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23478967      PMCID: PMC3632962          DOI: 10.1128/AAC.00001-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  48 in total

1.  Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes.

Authors:  Sünje Johanna Pamp; Morten Gjermansen; Helle Krogh Johansen; Tim Tolker-Nielsen
Journal:  Mol Microbiol       Date:  2008-02-28       Impact factor: 3.501

2.  Cationic amphiphiles increase activity of aminoglycoside antibiotic tobramycin in the presence of airway polyelectrolytes.

Authors:  Kirstin R Purdy Drew; Lori K Sanders; Zachary W Culumber; Olena Zribi; Gerard C L Wong
Journal:  J Am Chem Soc       Date:  2009-01-21       Impact factor: 15.419

3.  Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum.

Authors:  R Bucki; F J Byfield; P A Janmey
Journal:  Eur Respir J       Date:  2007-01-10       Impact factor: 16.671

4.  DNase1L2 suppresses biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  L Eckhart; H Fischer; K B Barken; T Tolker-Nielsen; E Tschachler
Journal:  Br J Dermatol       Date:  2007-04-25       Impact factor: 9.302

5.  Roles of type IV pili, flagellum-mediated motility and extracellular DNA in the formation of mature multicellular structures in Pseudomonas aeruginosa biofilms.

Authors:  Kim B Barken; Sünje J Pamp; Liang Yang; Morten Gjermansen; Jacob J Bertrand; Mikkel Klausen; Michael Givskov; Cynthia B Whitchurch; Joanne N Engel; Tim Tolker-Nielsen
Journal:  Environ Microbiol       Date:  2008-05-15       Impact factor: 5.491

6.  Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa.

Authors:  Liang Yang; Kim B Barken; Mette E Skindersoe; Allan B Christensen; Michael Givskov; Tim Tolker-Nielsen
Journal:  Microbiology       Date:  2007-05       Impact factor: 2.777

7.  Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa.

Authors:  Peter Ø Jensen; Thomas Bjarnsholt; Richard Phipps; Thomas B Rasmussen; Henrik Calum; Lars Christoffersen; Claus Moser; Paul Williams; Tacjana Pressler; Michael Givskov; Niels Høiby
Journal:  Microbiology       Date:  2007-05       Impact factor: 2.777

8.  Distribution, organization, and ecology of bacteria in chronic wounds.

Authors:  Klaus Kirketerp-Møller; Peter Ø Jensen; Mustafa Fazli; Kit G Madsen; Jette Pedersen; Claus Moser; Tim Tolker-Nielsen; Niels Høiby; Michael Givskov; Thomas Bjarnsholt
Journal:  J Clin Microbiol       Date:  2008-05-28       Impact factor: 5.948

9.  Role of autolysin-mediated DNA release in biofilm formation of Staphylococcus epidermidis.

Authors:  Zhiqiang Qin; Yuanzhu Ou; Liang Yang; Yuli Zhu; Tim Tolker-Nielsen; Soeren Molin; Di Qu
Journal:  Microbiology       Date:  2007-07       Impact factor: 2.777

10.  Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms.

Authors:  Heidi Mulcahy; Laetitia Charron-Mazenod; Shawn Lewenza
Journal:  PLoS Pathog       Date:  2008-11-21       Impact factor: 6.823

View more
  110 in total

1.  Residence in biofilms allows Burkholderia cepacia complex (Bcc) bacteria to evade the antimicrobial activities of neutrophil-like dHL60 cells.

Authors:  Mark P Murphy; Emma Caraher
Journal:  Pathog Dis       Date:  2015-09-13       Impact factor: 3.166

2.  Microbial glycoside hydrolases as antibiofilm agents with cross-kingdom activity.

Authors:  Brendan D Snarr; Perrin Baker; Natalie C Bamford; Yukiko Sato; Hong Liu; Mélanie Lehoux; Fabrice N Gravelat; Hanna Ostapska; Shane R Baistrocchi; Robert P Cerone; Elan E Filler; Matthew R Parsek; Scott G Filler; P Lynne Howell; Donald C Sheppard
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-20       Impact factor: 11.205

3.  Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model.

Authors:  Hajira Bilal; Phillip J Bergen; Tae Hwan Kim; Seung Eun Chung; Anton Y Peleg; Antonio Oliver; Roger L Nation; Cornelia B Landersdorfer
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

4.  Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms.

Authors:  Chase Watters; Jake A Everett; Cecily Haley; Allie Clinton; Kendra P Rumbaugh
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

5.  Glutathione-Disrupted Biofilms of Clinical Pseudomonas aeruginosa Strains Exhibit an Enhanced Antibiotic Effect and a Novel Biofilm Transcriptome.

Authors:  William Klare; Theerthankar Das; Amaye Ibugo; Edwina Buckle; Mike Manefield; Jim Manos
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

6.  Extracellular DNA impedes the transport of vancomycin in Staphylococcus epidermidis biofilms preexposed to subinhibitory concentrations of vancomycin.

Authors:  Natalya Doroshenko; Boo Shan Tseng; Robert P Howlin; Jill Deacon; Julian A Wharton; Philipp J Thurner; Brendan F Gilmore; Matthew R Parsek; Paul Stoodley
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

7.  Role of Viscoelasticity in Bacterial Killing by Antimicrobials in Differently Grown Pseudomonas aeruginosa Biofilms.

Authors:  René T Rozenbaum; Henny C van der Mei; Willem Woudstra; Ed D de Jong; Henk J Busscher; Prashant K Sharma
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

8.  Gene Transfer Efficiency in Gonococcal Biofilms: Role of Biofilm Age, Architecture, and Pilin Antigenic Variation.

Authors:  Nadzeya Kouzel; Enno R Oldewurtel; Berenike Maier
Journal:  J Bacteriol       Date:  2015-05-11       Impact factor: 3.490

Review 9.  Pseudomonas aeruginosa biofilms in disease.

Authors:  Lawrence R Mulcahy; Vincent M Isabella; Kim Lewis
Journal:  Microb Ecol       Date:  2013-10-06       Impact factor: 4.552

10.  Disruption and eradication of P. aeruginosa biofilms using nitric oxide-releasing chitosan oligosaccharides.

Authors:  Katelyn P Reighard; David B Hill; Graham A Dixon; Brittany V Worley; Mark H Schoenfisch
Journal:  Biofouling       Date:  2015       Impact factor: 3.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.